{"id":"guaiacol","rwe":[{"pmid":"41905227","year":"2026","title":"Exploring the possible translocation of smoke-derived volatile phenols from grapevine leaves to fruit.","finding":"","journal":"Food chemistry","studyType":"Clinical Study"},{"pmid":"41895926","year":"2026","title":"Kilning with smoke-affected air impacts the chemical and aromatic qualities of Cascade hops.","finding":"","journal":"Food research international (Ottawa, Ont.)","studyType":"Clinical Study"},{"pmid":"41893726","year":"2026","title":"Cellular Responses of Maize Roots to Long-Term Cadmium Exposure: Adjustments of Class III Peroxidases, Plasma Membrane and Tonoplast Sub-Proteomes.","finding":"","journal":"Proteomes","studyType":"Clinical Study"},{"pmid":"41890289","year":"2026","title":"Diversity of volatile phenols and their newly identified precursors during different grape species development.","finding":"","journal":"Frontiers in plant science","studyType":"Clinical Study"},{"pmid":"41886130","year":"2026","title":"Role of Acacia bark biochar in the growth of Ocimum basilicum L. under cadmium stress.","finding":"","journal":"Biodegradation","studyType":"Clinical Study"}],"tags":[{"label":"guaiacol","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Carbonic anhydrase 2","category":"target"},{"label":"CA2","category":"gene"},{"label":"CA1","category":"gene"},{"label":"Dental","category":"route"},{"label":"Paste","category":"form"},{"label":"Active","category":"status"},{"label":"Common cold","category":"indication"},{"label":"Cough","category":"indication"},{"label":"Nasal congestion","category":"indication"},{"label":"Nasal discharge","category":"indication"},{"label":"Rhinitis","category":"indication"}],"phase":"marketed","safety":{"contraindications":["Acidosis","Acute abdominal pain","Acute hepatitis","Acute nephropathy","Acute pancreatitis","Adrenal cortical hypofunction","Alcohol intoxication","Alcohol withdrawal delirium","Angle-closure glaucoma","Anuria","Arterial thrombosis","Arteriosclerotic vascular disease","Asthenia","Azotemia","Benign intracranial hypertension","Benign prostatic hyperplasia","Bladder outflow obstruction","Bradycardia","Breastfeeding (mother)","Central nervous system depression","Chronic heart failure","Chronic idiopathic constipation","Coma","Conduction disorder of the heart","Constipation"]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=GUAIACOL","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:28:32.262660+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-20T01:04:25.460308+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:28:37.764884+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=GUAIACOL","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:28:37.964010+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL13766/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:28:38.660112+00:00"}},"allNames":"guaiastil","offLabel":[],"synonyms":["guaiacol","2-methoxyphenol","guaiastil","methylcatechol"],"timeline":[],"aiSummary":"Guaiastil, a marketed drug by an unspecified company, operates uniquely by inhibiting carbonic anhydrase 2 to reduce mucus production, primarily indicated for the common cold. Its key competitive advantage lies in its distinct mechanism of action compared to off-patent drugs like acetazolamide and acetohydroxamic acid, which also target carbonic anhydrase but are widely available as generics. The primary risk is the patent expiry in 2028, which could lead to increased competition from generic versions.","approvals":[{"date":"","orphan":false,"company":"","regulator":"FDA"}],"brandName":"Guaiastil","ecosystem":[{"indication":"Common cold","otherDrugs":[{"name":"acetylsalicylic acid","slug":"acetylsalicylic-acid","company":"Endo Pharms"},{"name":"acrivastine","slug":"acrivastine","company":"Auxilium Pharms Inc"},{"name":"ammonium chloride","slug":"ammonium-chloride","company":"B Braun"},{"name":"azatadine","slug":"azatadine","company":""}],"globalPrevalence":null},{"indication":"Cough","otherDrugs":[{"name":"ammonium chloride","slug":"ammonium-chloride","company":"B Braun"},{"name":"benzocaine","slug":"benzocaine","company":""},{"name":"benzonatate","slug":"benzonatate","company":"Pfizer"},{"name":"bromazine","slug":"bromazine","company":"Forest Labs"}],"globalPrevalence":null},{"indication":"Nasal congestion","otherDrugs":[{"name":"acrivastine","slug":"acrivastine","company":"Auxilium Pharms Inc"},{"name":"alimemazine","slug":"alimemazine","company":"Allergan Herbert"},{"name":"ammonium chloride","slug":"ammonium-chloride","company":"B Braun"},{"name":"antazoline","slug":"antazoline","company":"Novartis"}],"globalPrevalence":null},{"indication":"Nasal discharge","otherDrugs":[{"name":"acrivastine","slug":"acrivastine","company":"Auxilium Pharms Inc"},{"name":"alimemazine","slug":"alimemazine","company":"Allergan Herbert"},{"name":"ammonium chloride","slug":"ammonium-chloride","company":"B Braun"},{"name":"antazoline","slug":"antazoline","company":"Novartis"}],"globalPrevalence":30000000},{"indication":"Rhinitis","otherDrugs":[{"name":"beclometasone dipropionate","slug":"beclometasone-dipropionate","company":""},{"name":"clofedanol","slug":"clofedanol","company":""},{"name":"codeine","slug":"codeine","company":"Ani Pharms"},{"name":"dextromethorphan","slug":"dextromethorphan","company":"Ani Pharms"}],"globalPrevalence":null}],"mechanism":{"target":"Carbonic anhydrase 2","novelty":"First-in-class","targets":[{"gene":"CA2","source":"DrugCentral","target":"Carbonic anhydrase 2","protein":"Carbonic anhydrase 2"},{"gene":"CA1","source":"DrugCentral","target":"Carbonic anhydrase 1","protein":"Carbonic anhydrase 1"}],"modality":"Small Molecule","drugClass":"guaiacol","explanation":"","oneSentence":"","technicalDetail":"Guaiastil inhibits carbonic anhydrase 2 (CA2), an enzyme involved in the regulation of bicarbonate and chloride ion transport, which contributes to the production of respiratory secretions."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1334","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=GUAIACOL","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=GUAIACOL","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:49:02.531148","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:28:40.298129+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[{"drugName":"acetazolamide","drugSlug":"acetazolamide","fdaApproval":"1953-07-27","genericCount":29,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"acetohydroxamic acid","drugSlug":"acetohydroxamic-acid","fdaApproval":"1983-05-31","patentStatus":"Unknown","relationship":"same-target"},{"drugName":"bendroflumethiazide","drugSlug":"bendroflumethiazide","fdaApproval":"1959-12-07","patentStatus":"Unknown","relationship":"same-target"},{"drugName":"benzthiazide","drugSlug":"benzthiazide","fdaApproval":"1960-10-14","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"bortezomib","drugSlug":"bortezomib","fdaApproval":"2003-05-13","patentExpiry":"Sep 23, 2042","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"brinzolamide","drugSlug":"brinzolamide","fdaApproval":"1998-04-01","genericCount":3,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"cefuroxime","drugSlug":"cefuroxime","fdaApproval":"1983-10-19","genericCount":10,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"celecoxib","drugSlug":"celecoxib","fdaApproval":"1998-12-31","patentExpiry":"May 27, 2036","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"chlorothiazide","drugSlug":"chlorothiazide","fdaApproval":"1958-09-04","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"chlortalidone","drugSlug":"chlortalidone","fdaApproval":"1960-04-07","relationship":"same-target"}],"genericName":"guaiacol","indications":{"approved":[{"name":"Common cold","source":"DrugCentral","snomedId":82272006,"regulator":"FDA"},{"name":"Cough","source":"DrugCentral","snomedId":49727002,"regulator":"FDA"},{"name":"Nasal congestion","source":"DrugCentral","snomedId":68235000,"regulator":"FDA"},{"name":"Nasal discharge","source":"DrugCentral","snomedId":64531003,"regulator":"FDA","usPrevalence":null,"globalPrevalence":30000000,"prevalenceMethod":"curated","prevalenceSource":"Influenza Other Respir Viruses, 2023 (PMID:36824394)"},{"name":"Rhinitis","source":"DrugCentral","snomedId":70076002,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"acetazolamide","brandName":"acetazolamide","genericName":"acetazolamide","approvalYear":"1953","relationship":"same-target"},{"drugId":"acetohydroxamic-acid","brandName":"acetohydroxamic acid","genericName":"acetohydroxamic acid","approvalYear":"1983","relationship":"same-target"},{"drugId":"bendroflumethiazide","brandName":"bendroflumethiazide","genericName":"bendroflumethiazide","approvalYear":"1959","relationship":"same-target"},{"drugId":"benzthiazide","brandName":"benzthiazide","genericName":"benzthiazide","approvalYear":"1960","relationship":"same-target"},{"drugId":"bortezomib","brandName":"bortezomib","genericName":"bortezomib","approvalYear":"2003","relationship":"same-target"},{"drugId":"brinzolamide","brandName":"brinzolamide","genericName":"brinzolamide","approvalYear":"1998","relationship":"same-target"},{"drugId":"cefuroxime","brandName":"cefuroxime","genericName":"cefuroxime","approvalYear":"1983","relationship":"same-target"},{"drugId":"celecoxib","brandName":"celecoxib","genericName":"celecoxib","approvalYear":"1998","relationship":"same-target"},{"drugId":"chlorothiazide","brandName":"chlorothiazide","genericName":"chlorothiazide","approvalYear":"1958","relationship":"same-target"},{"drugId":"chlortalidone","brandName":"chlortalidone","genericName":"chlortalidone","approvalYear":"1960","relationship":"same-target"}],"trialDetails":[{"nctId":"NCT07398924","phase":"NA","title":"Vaginal Estradiol and Oral Guaifenesin in Clomiphene Ovulation Induction","status":"COMPLETED","sponsor":"Yuzuncu Yil University","startDate":"2022-01-06","conditions":["Female Infertility","Anovulatory Infertility","Unexplained Infertility"],"enrollment":90,"completionDate":"2023-06-23"},{"nctId":"NCT05603832","phase":"PHASE3","title":"A Phase 3 Study of F14 for Management of Pain Following Total Knee Replacement","status":"COMPLETED","sponsor":"Arthritis Innovation Corporation","startDate":"2022-11-17","conditions":["Post Operative Pain"],"enrollment":151,"completionDate":"2024-08-23"},{"nctId":"NCT07230717","phase":"NA","title":"Evaluation of Pulpotomy Versus Pulpectomy in Primary Molars With Irreversible Pulpitis or Necrotic Pulp","status":"NOT_YET_RECRUITING","sponsor":"Ajman University","startDate":"2025-12-01","conditions":["Pulp Therapy","Pulpitis - Irreversible","Pulp Necrosis"],"enrollment":30,"completionDate":"2027-05-01"},{"nctId":"NCT06659965","phase":"","title":"Intravenous Methocarbamol for Acute Pain After Spine Surgery","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2020-01-01","conditions":["Acute Post Operative Pain","Postsurgical Pain Management","Spine Surgery","Acute Pain, Postoperative","Multimodal Analgesia"],"enrollment":1270,"completionDate":"2025-06-30"},{"nctId":"NCT05100017","phase":"NA","title":"Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2021-09-30","conditions":["Kidney Calculi","Kidney Diseases","Nephrolithiasis","Urolithiasis","Ureteral Diseases","Ureteral Calculi"],"enrollment":126,"completionDate":"2025-12"},{"nctId":"NCT05388929","phase":"PHASE4","title":"Methocarbamol in Ventral and Inguinal HR","status":"ACTIVE_NOT_RECRUITING","sponsor":"Prisma Health-Upstate","startDate":"2022-06-23","conditions":["Ventral Hernia","Inguinal Hernia"],"enrollment":164,"completionDate":"2026-12"},{"nctId":"NCT05076110","phase":"PHASE4","title":"Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2022-04-07","conditions":["Hip Arthroscopy"],"enrollment":188,"completionDate":"2026-04"},{"nctId":"NCT03272295","phase":"NA","title":"A Nicotine Pharmacokinetics and Smoking Behaviour Study Examining Cigarette Ingredients","status":"COMPLETED","sponsor":"British American Tobacco (Investments) Limited","startDate":"2017-09-12","conditions":["Healthy Volunteers","Smoking"],"enrollment":40,"completionDate":"2017-12-08"},{"nctId":"NCT00000752","phase":"PHASE2","title":"Preventing Frequent Sinus Infections in HIV-Infected Patients","status":"WITHDRAWN","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":["HIV Infections","Sinusitis"],"enrollment":0,"completionDate":"1993-02"},{"nctId":"NCT01297959","phase":"PHASE3","title":"Study to Evaluate Efficacy and Safety of E-101 Solution for Preventing Surgical Site Infections After Colorectal Surgery","status":"COMPLETED","sponsor":"Excited States, LLC","startDate":"2013-01-10","conditions":["Infections"],"enrollment":503,"completionDate":"2015-10-14"},{"nctId":"NCT01202279","phase":"PHASE4","title":"Safety and Efficacy Study of Guaifenesin and Pseudoephedrine for Symptomatic Therapy to Treat Acute RTI","status":"COMPLETED","sponsor":"Reckitt Benckiser Inc.","startDate":"2009-10","conditions":["Acute Upper Respiratory Track Infection"],"enrollment":1179,"completionDate":"2010-07"},{"nctId":"NCT01046136","phase":"PHASE2","title":"Mucinex Exploratory Cold Study","status":"COMPLETED","sponsor":"Reckitt Benckiser Inc.","startDate":"2009-12","conditions":["Common Cold"],"enrollment":378,"completionDate":""},{"nctId":"NCT01364467","phase":"PHASE2","title":"The Effect of Oral Guaifenesin on Pediatric Chronic Rhinitis: A Pilot Study","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2011-05","conditions":["Chronic Rhinitis"],"enrollment":30,"completionDate":"2018-03-05"},{"nctId":"NCT02859246","phase":"NA","title":"Mucinex® for Treatment of Filamentary Keratitis","status":"COMPLETED","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2016-09","conditions":["Filamentary Keratitis"],"enrollment":15,"completionDate":"2018-07"},{"nctId":"NCT02432456","phase":"PHASE4","title":"Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2015-09","conditions":["Wounds and Injuries","Rib Fractures"],"enrollment":153,"completionDate":"2018-08"},{"nctId":"NCT02879981","phase":"","title":"A Safety Study of Balsamic Bactrim in Pediatric Participants With Acute Bronchitis","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2016-11-10","conditions":["Bronchitis"],"enrollment":51,"completionDate":"2017-08-28"},{"nctId":"NCT03642873","phase":"PHASE1","title":"Study to Evaluate Drug-drug Interactions of Guaifenesin and Hydrocodone Bitartrate","status":"COMPLETED","sponsor":"Reckitt Benckiser LLC","startDate":"2007-05-05","conditions":["Healthy Subjects"],"enrollment":24,"completionDate":"2007-05-21"},{"nctId":"NCT03644095","phase":"PHASE1","title":"Bioequivalence Study Comparing Mucinex Extended-release 600 mg Tablets to Immediate-release Guaifenesin 600 mg in Healthy Volunteers","status":"COMPLETED","sponsor":"Reckitt Benckiser Inc.","startDate":"2009-01-16","conditions":["Healthy Subjects"],"enrollment":30,"completionDate":"2009-02-01"},{"nctId":"NCT03642262","phase":"PHASE1","title":"Mucinex® ER 600 mg Bi-layer Tablet Versus Guaifenesin Immediate Release (IR) 200 mg q4h","status":"COMPLETED","sponsor":"Reckitt Benckiser Inc.","startDate":"2013-06-02","conditions":["Healthy Subjects"],"enrollment":30,"completionDate":"2013-08-09"},{"nctId":"NCT01257243","phase":"PHASE3","title":"Comparison Between Oxomemazine, Guaifenesin and Potassium Iodate Versus Guaifenesin Monotherapy in Acute Cough Treatment","status":"COMPLETED","sponsor":"EMS","startDate":"2012-10-01","conditions":["Cough"],"enrollment":260,"completionDate":"2013-10-25"},{"nctId":"NCT03649750","phase":"PHASE1","title":"Mucinex® ER 600 mg Bi-Layer Tablet Fed and Fasted","status":"COMPLETED","sponsor":"Reckitt Benckiser LLC","startDate":"2013-05-29","conditions":["Healthy Subjects"],"enrollment":36,"completionDate":"2013-08-07"},{"nctId":"NCT03633487","phase":"PHASE1","title":"Study to Evaluate the Pharmacokinetics of Mucinex® 1200 mg Extended-Release Tablet","status":"COMPLETED","sponsor":"Reckitt Benckiser LLC","startDate":"2011-10-11","conditions":["Healthy Subjects"],"enrollment":24,"completionDate":"2011-10-15"},{"nctId":"NCT03644108","phase":"PHASE1","title":"Study to Evaluate the Pharmacokinetics of Mucinex 600 mg Extended-release Bi-layer Tablet in Healthy Volunteers","status":"COMPLETED","sponsor":"Reckitt Benckiser Inc.","startDate":"2009-06-04","conditions":["Healthy Subjects"],"enrollment":30,"completionDate":"2009-06-15"},{"nctId":"NCT03706300","phase":"PHASE1","title":"Bioequivalence Study of Guaifenesin and Pseudoephedrine Hydrochloride Extended Release Tablets 1200/120 mg Under Fasting Conditions","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2014-12","conditions":["Healthy"],"enrollment":80,"completionDate":"2015-01"},{"nctId":"NCT02642874","phase":"PHASE3","title":"Methocarbamol in Treatment of Muscle Cramps in Cirrhotic Patients","status":"UNKNOWN","sponsor":"Tanta University","startDate":"2017-04-01","conditions":["Liver Cirrhosis"],"enrollment":200,"completionDate":"2020-12"},{"nctId":"NCT02831569","phase":"PHASE3","title":"Japanese IP-TN Trial","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2016-07-27","conditions":["Pain"],"enrollment":80,"completionDate":"2016-10-19"},{"nctId":"NCT03213353","phase":"PHASE1","title":"A Bioequivalence Study Between Two Brands of Medications to Treat Cough & Cold Symptoms","status":"COMPLETED","sponsor":"Johnson & Johnson Consumer and Personal Products Worldwide","startDate":"2017-07-03","conditions":["Bioequivalence","Healthy Volunteers"],"enrollment":72,"completionDate":"2017-07-17"},{"nctId":"NCT02665286","phase":"PHASE4","title":"Orphenadrine and Methocarbamol for LBP","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"2016-03","conditions":["Low Back Pain"],"enrollment":240,"completionDate":"2017-05"},{"nctId":"NCT02581397","phase":"PHASE3","title":"Transpulmin Suppository and Guaiacol Compared to Transpulmin Syrup in Pediatric Participants With Productive Cough","status":"TERMINATED","sponsor":"Ache Laboratorios Farmaceuticos S.A.","startDate":"2015-05-05","conditions":["Cough"],"enrollment":270,"completionDate":"2016-12-06"},{"nctId":"NCT02902640","phase":"","title":"A Non-Interventional Safety Study of Balsamic Bactrim","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2016-11-15","conditions":["Bronchitis"],"enrollment":52,"completionDate":"2017-07-31"},{"nctId":"NCT02157649","phase":"PHASE1","title":"Single Dose Trial of Extended Release Combination Tablet Codeine and Guaifenesin","status":"COMPLETED","sponsor":"Nexgen Pharma, Inc","startDate":"2014-06","conditions":["Cough"],"enrollment":26,"completionDate":"2014-09"},{"nctId":"NCT01562548","phase":"NA","title":"Exploratory Efficacy Study of Guaifenesin in Upper Back Pain","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2012-02","conditions":["Upper Back Pain"],"enrollment":78,"completionDate":"2013-05"},{"nctId":"NCT02069665","phase":"NA","title":"Effectiveness Study of Integrative Treatment for Pediatric Pneumonia","status":"COMPLETED","sponsor":"Liaoning University of Traditional Chinese Medicine","startDate":"2011-12","conditions":["Pneumonia"],"enrollment":451,"completionDate":"2013-08"},{"nctId":"NCT01537081","phase":"PHASE2,PHASE3","title":"Safety and Efficacy of Mucinex and IR Guaifenesin the Treatment of Symptoms of Acute Upper Respiratory Tract Infections","status":"COMPLETED","sponsor":"Reckitt Benckiser LLC","startDate":"2011-09","conditions":["Acute Upper Respiratory Tract Infection"],"enrollment":2810,"completionDate":"2012-07"},{"nctId":"NCT01576809","phase":"PHASE3","title":"Warming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Phenylephrine 10mg + Guaifenesin 200 mg Syrup in Patients Suffering a Upper Respiratory Tract Infection (URTI)","status":"COMPLETED","sponsor":"Novartis","startDate":"2012-03","conditions":["Upper Respiratory Infections"],"enrollment":51,"completionDate":"2012-05"},{"nctId":"NCT01062256","phase":"NA","title":"Study of Count Coughs in Subjects With Acute Upper Respiratory Tract Infections","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2010-01","conditions":["Infection"],"enrollment":265,"completionDate":"2010-02"},{"nctId":"NCT00377403","phase":"PHASE4","title":"Treatment of Acute Sinusitis","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2006-10","conditions":["Acute Respiratory Infections","Acute Rhinosinusitis"],"enrollment":172,"completionDate":"2010-08"},{"nctId":"NCT01119534","phase":"PHASE3","title":"Comparative Efficacy of the Suppository Versus Guaiacol Suppository Versus Guaifenesin Syrup in Pediatric Patients With Cough Due the Infectious Origin","status":"UNKNOWN","sponsor":"Azidus Brasil","startDate":"2011-05","conditions":["Cough"],"enrollment":270,"completionDate":"2011-12"},{"nctId":"NCT01085721","phase":"PHASE3","title":"Comparison Between Dexchlorpheniramine and Dexchlorpheniramine/Pseudoephedrine/Guaifenesin in Respiratory Infections","status":"UNKNOWN","sponsor":"Mantecorp Industria Quimica e Farmaceutica Ltd.","startDate":"","conditions":["Viral Infections of the Upper Respiratory Tract"],"enrollment":170,"completionDate":""},{"nctId":"NCT00441246","phase":"PHASE4","title":"Phase 4 Study - Mucinex D as Adjunct Therapy","status":"COMPLETED","sponsor":"Adams Respiratory Therapeutics","startDate":"2007-02","conditions":["Acute Respiratory Infection","Bronchitis","Rhinosinusitis"],"enrollment":600,"completionDate":"2007-07"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Dental","formulation":"Paste","formulations":[{"form":"PASTE","route":"DENTAL","productName":"Dry Socket"}]},"crossReferences":{"NUI":"N0000148129","MMSL":"12074","NDDF":"003178","UNII":"6JKA7MAH9C","VUID":"4020199","CHEBI":"CHEBI:28591","VANDF":"4020199","RXNORM":"5031","UMLSCUI":"C0018304","chemblId":"CHEMBL13766","ChEMBL_ID":"CHEMBL13766","KEGG_DRUG":"D00117","DRUGBANK_ID":"DB11359","PDB_CHEM_ID":" JZ3","PUBCHEM_CID":"460","SNOMEDCT_US":"424656002","MESH_DESCRIPTOR_UI":"D006139"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":3338,"therapeuticAreas":["Infectious Disease"],"biosimilarFilings":[],"recentPublications":[{"date":"2026 Mar 24","pmid":"41905227","title":"Exploring the possible translocation of smoke-derived volatile phenols from grapevine leaves to fruit.","journal":"Food chemistry"},{"date":"2026 May 31","pmid":"41895926","title":"Kilning with smoke-affected air impacts the chemical and aromatic qualities of Cascade hops.","journal":"Food research international (Ottawa, Ont.)"},{"date":"2026 Feb 25","pmid":"41893726","title":"Cellular Responses of Maize Roots to Long-Term Cadmium Exposure: Adjustments of Class III Peroxidases, Plasma Membrane and Tonoplast Sub-Proteomes.","journal":"Proteomes"},{"date":"2026","pmid":"41890289","title":"Diversity of volatile phenols and their newly identified precursors during different grape species development.","journal":"Frontiers in plant science"},{"date":"2026 Mar 26","pmid":"41886130","title":"Role of Acacia bark biochar in the growth of Ocimum basilicum L. under cadmium stress.","journal":"Biodegradation"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:28:40.298129+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}